TrialThe Journal of infectious diseases2020

Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.

Donald D Anthony et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.